Partnership is a novel cross-sector collaboration, responding to the
United Nations call to tackle non-communicable diseases (NCDs)
Initiative goes beyond awareness-raising campaigns by prompting
Strategically combining expertise from pharmaceutical and
humanitarian sectors, this initiative is expected to reach three
GENEVA, March 19, 2013 /CNW/ - The International Federation of
Pharmaceutical Manufacturers & Associations (IFPMA) and the
International Federation of Red Cross and Red Crescent Societies (IFRC)
announced today a partnership on NCD prevention. The two-year
partnership involves support from both organizations to design a
behavioral change-based toolkit that promotes healthy lifestyle choices
at national and community levels. Through its volunteer network and
community-based expertise, the IFRC will make the toolkit available to
approximately 3 million people worldwide.
The four main NCDs- cardiovascular diseases, cancer, chronic respiratory
diseases and diabetes - kill three in five people worldwide, with 80
percent of NCD-related deaths occurring in low- and middle-income
Because 50 percent of NCDs are avoidable, the IFPMA-IFRC partnership
enhances efforts by both organizations to combat NCDs worldwide and
support IFRC community interventions to reduce the impact of these
diseases locally. Since releasing its Framework for Action on NCDs in
2011, IFPMA has delivered a series of research projects and health
education initiatives to identify new ways to help people fight NCDs.
"By leveraging IFRC's and IFPMA's shared goal of fighting NCDs, this
novel partnership brings synergy and creativity to fighting these
diseases globally," says Eduardo Pisani, IFPMA Director General.
One of IFRC's core strengths lies in community volunteers' ability to
tackle the underlying social, behavioral and environmental factors that
determine good health through their on-the-ground work. "Changing
behaviors by eliminating shared risk factors can save lives. Red Cross
Red Crescent volunteers, going door-to-door in their communities play a
vital role in promoting healthy lifestyles," says Bekele Geleta, IFRC
Secretary General. "But no one single player from the public or private
sector working in silo can tackle the NCDs challenges. Fighting NCDs
requires multi-stakeholders solutions."
About the IFPMA:
IFPMA represents the research-based pharmaceutical companies and
associations across the globe. The research-based pharmaceutical
industry's 1.3 million employees research, develop and provide
medicines and vaccines that improve the life of patients worldwide.
Based in Geneva, IFPMA has official relations with the United Nations
and contributes industry expertise to help the global health community
find solutions that improve global health.
SOURCE: The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
For further information:
Peter Shelby, IFPMA, Tel +41/22-338-3223, Mob +41/79-820-2599, email@example.com; Ali Karami-Ruiz, IFPMA, Tel +41/22-338-3229, Mob +41/78-850-2903, firstname.lastname@example.org